Case Study: Liminal BioSciences achieves rapid, compliant communication to investors, employees, and healthcare professionals with Uberflip

How a publicly traded company uses Uberflip to quickly reach investors, employees, & healthcare professionals

Liminal BioSciences is a NASDAQ-listed, clinical-stage biopharmaceutical company developing novel treatments. Facing strict disclosure requirements and the need for rapid, consistent communication with investors, healthcare professionals and employees, the company needed a way to quickly package and distribute time‑sensitive press releases, analyst materials and brand messaging while keeping internal teams informed.

Liminal uses the Uberflip content experience platform to publish branded assets code‑free in minutes, centralize content for investors and employees, and amplify materials via email and social. Built‑in analytics let the team track engagement and refine content, and an internal communications Hub set as employees’ home page ensures everyone sees the latest updates—resulting in faster market response, clearer investor outreach and improved internal alignment.

Liminal BioSciences

Shrinal Inamdar

Investor Relations and Communications Manager